Penn Medicine Abramson Cancer Center


 

ASH 2019 Update on New Developments in CML: Asciminib Effective in Pts with all ATP Pocket Mutations & Predicting Success of TFR

19 views
February 24, 2020
Comments 0
Login to view comments. Click here to Login